EUVIMEDEUVIMED entdecken
EditorialOpen Access

Inclusion of Racial and Ethnic Minorities in Cancer Clinical Trials: 30 Years After the NIH Revitalization Act, Where Are We?

Faith Mutale

Journal of the Advanced Practitioner in Oncology · 01.11.2022 · 13 (8) · 755-757

DOI: 10.6004/jadpro.2022.13.8.2 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 01.11.2022. Verfasst von Faith Mutale. Beteiligte Einrichtung: Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia. Die Arbeit wurde bisher 26-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lack of diversity in cancer trials is a multifaceted, decades-old problem that has remained persistent despite efforts to increase the number of participants from underrepresented racial and ethnic backgrounds. This lack of meaningful improvement is a problem that continues to perpetuate inequities in cancer care. For optimal generalizability of clinical trial results, populations that are likely to be treated must be adequately represented. Beyond consensus statements, policy enactments, and federal mandates, strategic collaboration with at-risk underrepresented communities is critically necessary to improve the accrual of minorities to cancer clinical trials. As such, the clarion call is for advanced practitioners in oncology to take a keen interest in this issue and seek to develop population-specific strategies to bridge and eliminate the disparity gap and improve outcomes in these groups.

Autor:innen und Institutionen

  • Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia.

Zitieren

APA

Mutale, F. (2022). Inclusion of Racial and Ethnic Minorities in Cancer Clinical Trials: 30 Years After the NIH Revitalization Act, Where Are We?. Journal of the Advanced Practitioner in Oncology, 13(8), 755-757. https://doi.org/10.6004/jadpro.2022.13.8.2

Vancouver

Mutale F. Inclusion of Racial and Ethnic Minorities in Cancer Clinical Trials: 30 Years After the NIH Revitalization Act, Where Are We?. Journal of the Advanced Practitioner in Oncology. 2022;13(8):755-757. doi:10.6004/jadpro.2022.13.8.2

BibTeX
@article{Mutale2022,
  author = {Mutale, Faith},
  title = {Inclusion of Racial and Ethnic Minorities in Cancer Clinical Trials: 30 Years After the NIH Revitalization Act, Where Are We?},
  journal = {Journal of the Advanced Practitioner in Oncology},
  year = {2022},
  volume = {13},
  number = {8},
  pages = {755--757},
  doi = {10.6004/jadpro.2022.13.8.2}
}
Kostenlos starten →